Open Access Article
International Journal of Clinical Research. 2025; 9: (7) ; 142-145 ; DOI: 10.12208/j.ijcr.20250352.
Observation on the clinical effect of combined treatment of Chinese (Uyghur) and western medicine for cervicitis complicated with HPV
中（维）西医结合治疗宫颈炎合并HPV的临床效果观察
作者：
夏代提古丽·艾力尼牙孜1 *,
古丽加娜提·依米提1,
阿尔祖古丽·苏来曼2
1 新疆维吾尔自治区第二人民医院（自治区维吾尔医医院） 新疆乌鲁木齐
2 沙雅县盖孜库木乡卫生院 新疆沙雅
*通讯作者：
夏代提古丽·艾力尼牙孜,单位： 新疆维吾尔自治区第二人民医院（自治区维吾尔医医院） 新疆乌鲁木齐；
发布时间: 2025-07-26 总浏览量: 34
PDF 全文下载
引用本文
摘要
目的 探究分析中（维）西医结合治疗宫颈炎合并HPV的临床效果。方法 时间：2021年1月至2025年1月，对象：宫颈炎合并HPV感染患者共64例，分组：随机分为对照组与观察组。对照组采用重组干扰素α2b凝胶治疗，观察组在对照组的基础上采用维医治疗。对比两组HPV转阴率；中医证候积分；炎症因子水平以及生活质量。结果 观察组优于对照组，P＜0.05。结论 中（维）西医结合治疗可显著改善患者HPV转阴率；中医证候积分；炎症因子水平以及生活质量，值得推广与应用。
关键词： 宫颈炎；HPV；中（维）西医结合；HPV转阴率；中医证候积分；炎症因子水平；生活质量
Abstract
Objective To investigate and analyze the clinical outcomes of combined (Chinese and Western) medicine treatment for cervical inflammation with HPV infection. Methods The study was conducted from January 2021 to January 2025, involving 64 patients with cervical inflammation and HPV infection. Patients were randomly divided into a control group and an observation group. The control group received treatment with recombinant interferon α2b gel, while the observation group received additional TCM treatment in addition to the control group. The study compared the HPV seroconversion rates, TCM syndrome scores, inflammatory factor levels, and quality of life between the two groups. Results The observation group showed significantly better outcomes than the control group, P<0.05. Conclusion Combined (Chinese and Western) medicine treatment can significantly improve the HPV seroconversion rate, TCM syndrome scores, inflammatory factor levels, and quality of life in patients with cervical inflammation and HPV infection, making it worthy of promotion and application.
Key words： Cervicitis; HPV; Combined Chinese (Western) medicine; HPV negative rate; TCM syndrome score; Inflammatory factor level; Quality of life
参考文献 References
[1] 何锋云,欧琰,丁莺,等.扶正解秽汤联合重组人干扰素治疗慢性宫颈炎合并高危型HPV感染临床研究[J].陕西中医,2024,45(05):605-609.
[2] 赵蓉华,熊琼,彭先桃.2b凝胶联合微波治疗宫颈炎合并HPV感染患者疗效及对宫颈COX-2表达、血PGE2表达水平的影响[J].智慧健康,2023,9(15):112-115+120.
[3] 黄达.加味完带汤治疗肝郁脾虚型慢性宫颈炎合并HPV感染的临床疗效及对血清hs-CRP、TNF-α及IL-6水平的影响[D].江西中医药大学,2022.
[4] 郭华林,贺燕.清热解毒除湿汤联合西药治疗急性宫颈炎的临床疗效及对症状缓解时间、分泌液炎性水平的影响[J].中医研究,2021,34(12):40-44.
[5] 梁茂新,高天舒.《中药新药临床研究指导原则》脏腑诸证考察与分析[J].中国中医基础医学杂志,2008,14(5): 330-331,342.
[6] 赵娜.复方沙棘籽油栓辅助重组人干扰素α-2b凝胶及微波治疗慢性宫颈炎伴HR-HPV感染患者的效果[J].河南医学研究,2020,29(33):6275-6277.
[7] 何锋云,欧琰,丁莺,等.扶正解秽汤联合重组人干扰素治疗慢性宫颈炎合并高危型HPV感染临床研究[J].陕西中医,2024,45(5):605-609.
[8] 常玉梅,张凤喜,王薇,等.复方沙棘籽油栓联合重组人干扰素α2b凝胶治疗慢性宫颈炎合并高危型人乳头瘤病毒感染疗效观察[J].河北中医,2021,43(06):969-971+991.
[9] 西仁古丽·牙生（Xiringul yasin）.子宫颈炎合并HPV感染维医证型分布规律及相关因素研究[D].新疆医科大学,2019.
引用本文
夏代提古丽·艾力尼牙孜, 古丽加娜提·依米提, 阿尔祖古丽·苏来曼, 中（维）西医结合治疗宫颈炎合并HPV的临床效果观察[J]. 国际临床研究杂志, 2025; 9: (7) : 142-145.